Health
Rapid CD169 assay for COVID-19 screening – News-Medical.Net
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory…
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The assay detects the upregulation of whole blood monocyte CD169, which has been reported as a marker of viral infections.
This rapid assay was more sensitive than the currently used method and less likely to produce false-negative results, especially among early and asymptomatic patients.
…
-
Noosa News23 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
General22 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
Noosa News21 hours agoFranz Ferdinand: Australian Tour 2025
-
Noosa News24 hours agoRider busted in risky act with dog on motorbike